Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | PI103 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNF-a | 21.5 | 34 | |
N2586 | Sigma A6730 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNF-a | 26.0 | 31 | |
N2586 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNF-a | 25.0 | 32 | |
N2586 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNF-a | 28.0 | 43 | |
0 | TNF-a | 16.0 | 84 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 3 | TNF-a | 28.0 | 69 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNF-a | 30.0 | 59 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNF-a | 18.0 | 62 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNF-a | 24.0 | 79 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNF-a | 21.0 | 69 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNF-a | 20.0 | 62 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | TNF-a | 33.0 | 75 | ||||
N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNF-a | 30.5 | 58 | |
N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNF-a | 33.0 | 73 | |
N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNF-a | 33.0 | 58 | |
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNF-a | 19.0 | 63 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNF-a | 29.0 | 70 | |
RA2159 | 3 | TNF-a | 18.0 | 79 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | TNF-a | 18.0 | 82 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | TNF-a | 16.5 | 64 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | TNF-a | 19.0 | 67 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | TNF-a | 15.0 | 82 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | TNF-a | 15.0 | 71 | ||||
RA2159 | 3 | TNF-a | 20.0 | 92 | |||||||
N2586 | 3 | TNF-a | 20.0 | 81 |